Evidence map›Paper›PMID 30525279›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2019

Morning surge in blood pressure and blood pressure variability in Asia: Evidence and statement from the HOPE Asia Network.

Guru P Sogunuru, Kazuomi Kario, Jinho Shin, Chen-Huan Chen, Peera Buranakitjaroen, Yook C Chia, Romeo Divinagracia, Jennifer Nailes, Sungha Park, Saulat Siddique and 8 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Target blood pressure and control status in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Trial
  4. Asian expert consensus on high-quality hypertension management.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Review
  5. Article
  6. Article
  7. Blood pressure status, JSH 2019-based control rate, and associated factors among community-dwelling adults: The NOSE study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The control rate of hypertension across months of year and hours of day in a large real-world database.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 14 institutions in 12 countries.

Guru P SogunuruMIOT International Hospital, Chennai, India.
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
Jinho ShinFaculty of Cardiology Service, Hanyang University Medical Center, Seoul, Korea.
Chen-Huan ChenDepartment of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
Peera BuranakitjaroenDepartment of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Yook C ChiaDepatment of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Romeo DivinagraciaUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.
Jennifer NailesUniversity of the East Ramon Magsaysay Memorial Medical Center Inc, Quezon City, Philippines.ORCID 0000-0001-6334-0510
Sungha ParkDivision of Cardiology, Cardiovascular Hospital, Yonsei Health System, Seoul, Korea.
Saulat SiddiquePunjab Medical Center, Lahore, Pakistan.
Jorge SisonDepartment of Medicine, Medical Center Manila, Manila, Philippines.
Arieska A SoenartaDepartment Cardiology and Vascular Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Jam C TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
Yuda TuranaDepartment of Neurology, Faculty of Medicine, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
Yuqing ZhangDivisions of Hypertension and Heart Failure, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Satoshi HoshideDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0001-7541-5751
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
HOPE Asia Network
Jichi Medical University · JPUniversity of the East Ramon Magsaysay Memorial Medical Center · PHAtma Jaya Catholic University of Indonesia · IDChinese Academy of Medical Sciences & Peking Union Medical College · CNHanyang University Medical Center · KRMadras Institute of Orthopaedics and Traumatology · INNational Yang Ming Chiao Tung University · TWPelita Harapan University · IDPunjab Medical Center · PKRuijin Hospital · CNSiriraj Hospital · THSunway University · MYTan Tock Seng Hospital · SGYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is a major risk factor for cardiovascular and cerebrovascular diseases. To effectively prevent end-organ damage, maintain vascular integrity and reduce morbidity and mortality, it is essential to decrease and adequately control blood pressure (BP) throughout each 24-hour period. Exaggerated early morning BP surge (EMBS) is one component of BP variability (BPV), and has been associated with an increased risk of stroke and cardiovascular events, independently of 24-hour average BP. BPV includes circadian, short-term and long-term components, and can best be documented using out-of-office techniques such as ambulatory and/or home BP monitoring. There is a large body of evidence linking both BPV and EMBS with increased rates of adverse cardio- and cerebrovascular events, and end-organ damage. Differences in hypertension and related cardiovascular disease rates have been reported between Western and Asian populations, including a higher rate of stroke, higher prevalence of metabolic syndrome, greater salt sensitivity and more common high morning and nocturnal BP readings in Asians. This highlights a need for BP management strategies that take into account ethnic differences. In general, long-acting antihypertensives that control BP throughout the 24-hour period are preferred; amlodipine and telmisartan have been shown to control EMBS more effectively than valsartan. Home and ambulatory BP monitoring should form an essential part of hypertension management, with individualized pharmacotherapy to achieve optimal 24-hour BP control particularly the EMBS and provide the best cardio- and cerebrovascular protection. Future research should facilitate better understanding of BPV, allowing optimization of strategies for the detection and treatment of hypertension to reduce adverse outcomes.

Indexed as

Antihypertensive AgentsAsiaBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryCircadian RhythmDisease ManagementHumansHypertensionAntihypertensive Agents24-hour blood pressureAsiablood pressure variabilitycardiovascular riskhypertensionmorning blood pressure surge

Identifiers

PMID30525279
PMCPMC8030409
OpenAlexW2904606810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.